MobbleOpen in Mobble ⇢
Health · Mental health · published 2026-10-11 · via MedPage Today

Ketamine Prescribing Risks Highlighted After High-Profile Deaths

Image via MedPage Today
Image via MedPage Today

The article examines ketamine prescribing in patients with addiction histories after the deaths of Presley Gerber and Matthew Perry. It notes that ketamine is approved as an anesthetic and esketamine is approved for treatment-resistant depression under a safety program, while off-label ketamine lacks similar oversight. Psychiatrists argue that inconsistent standards leave risks such as addiction unaddressed and call for stronger patient protections.

Expanded Detail

[paragraphs]

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at MedPage Today →
Related stories
Matching Patients to Ketamine Variants: Clinical Strategies for Treatment-Resistant Depression · Mental health
Reframing Treatment-Resistant Depression as Difficult-to-Treat Depression · Mental health
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “The Liability Behind Ketamine's Promise.” Browse more stories.